eShowcase
Think of Teranode's modeling software program as the world's most sophisticated blackboard
Think of Teranode's modeling software program as the world's most sophisticated blackboard
Teranode's (Seattle, WA) capabilities as a design automation software company incorporates some of the better elements of spreadsheets, Visio, dry-erase boards, and databases.
eShowcase
Its product, the recently revamped Teranode Design Suite V2™, is a tool to turn the sometimes-challenging protocol design into an easy-to-read flow chart that just happens to works as a data repository as well. The closed-loop R&D platform lets sponsors use one program to design their workflow, instead of cobbling together aspects of half a dozen other products for an ad hoc solution. That workflow can be used all trial long.
Teranode Design Suite V2â¢
V2 includes a visual model of both biochemical and protocol systems. That model can be integrated to lab data or analytics, which makes for easier simulation, charting, and reporting. And multiple users can work on the same model, easing collaboration.
The first step a sponsor should make when designing a study is setting up the protocols, not calling in engineers to design an informatics platform. The tail should not wag the dog, which is why Teranode was designed. It easily portrays all the elements of a protocol great and small, letting the sponsor run the trial.
Teranode, (206) 219-3000, www.teranode.com
There is no Office Depot for clinical trial supplies, but there is First Marketing's online store
First Marketing (Pompano Beach, FL) wants to give sponsors flexibility in both purchasing and monitoring site supplies.
(Pi)SiteSourceâ¢
The company already runs the Patient Interaction service, which offers a gamut of services: site analysis, PR, Web and interactive services, patient education, marketing campaigns, even physician referral programs. In other words, everything but the kitchen sink.
Its (Pi)Site Solution is an online ordering system for clinical trial supplies. The site gets to choose what they want, but the sponsor gets to make sure they meet any IRB requirements. Choose from flyers, brochures, thank you cards, direct mailers, newsletters, informed consent media, or newspaper ads.
Sponsors can see exactly what is being requested by a site. That data can be compared with enrollment and retention rates to see why one site needs twice as many supplies as a second, if they have the same number of recruited subjects.
There's also a function to customize the materials with personalized info: a site logo, contact numbers, and even a picture of the lead investigator. The ordering site and the materials are available in multiple languages as well.
First Marketing, (954) 979-0700, www.first-marketing.com or www.patientinteraction.com
Enter the matrix management system with Zorch's new addition to its IDS suite of pharma business programs
Zorch Software (Salt Lake City, UT) already has a full Integrated Development System to cover project management. So what does its new Matrix Manager offer?
Matrix Managerâ¢
In a word, oversight. The program allows departmental managers who have multiple projects on their desks to check out the resource allocation for all of them, at the same time. Managers can allocate funds and resources to cross-functional projects, to ensure that all projects stay guided by the ultimate vision of the sponsor.
The manager who had just one trial to monitor is rare nowadays. With different emphases, different phases, many different locations and different protocols, keeping all the ducks in a row is a challenging task. Matrix Manager allows executives to take advantage of a matrix organizational style.
This is in addition to the existing Zorch IDS products which boast to accelerate time-to market for INDs, NDAs, or ANDA submissions, and improve the product commercialization process.
Zorch Software, (801) 957-5333, www.zorchsoftware.com
Send your new product info to: Jeff Ryan, jryan@advanstar.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
